DOW JONES20,943.51-973.65 -4.44%
S&P 5002,470.50-114.09 -4.41%
NASDAQ7,360.58-339.52 -4.41%

AcelRx Sees Prelim. FY19 Sales $2.3M, Cash, Cash Equivalents And Short-Term Investments Of $66.1M As Of Dec. 31

Benzinga · 01/13/2020 12:18